ASCO 2026: GLP-1 Receptor Agonists May Reduce Mortality in Patients With Cancer
In this interview with Pharmacy Times at the 2026 American Society of Clinical Oncology Annual Meeting, Jessica Paulus, ScD, Vice President, Real-World Research, Ontada, discusses new research showing a 34% reduction in mortality among patients with 6 cancer types—including breast, prostate, colorectal, hepatocellular, and renal cell carcinoma—who received glucagon-like peptide-1 (GLP-1) receptor agonists. Paulus explains that although the epidemiologic study was not designed to determine causation, potential mechanisms may include reduced inflammation, improved glycemic control, decreased adipose tissue burden, and possible direct effects on cancer cell proliferation. You can find more expert insights at PharmacyTimes.com, where we provide pharmacy news, clinical insights, & continuing education to help pharmacists deliver drug expertise & accessible patient care. Original Interview: https://www.pharmacytimes.com/view/gl... Visit Pharmacy Times: https://www.pharmacytimes.com/ Follow Pharmacy Times on social media! X: @Pharmacy_Times Facebook: Pharmacy Times LinkedIn: Pharmacy Times BlueSky: @PharmacyTimes.bsky.social TikTok: @pharmacytimes #pharmacy #politics #pharma #pharmacist #ASCO #glp1 #oncology #cancerawareness
The Future of Localized Prostate Cancer Treatment: Mary-Ellen Taplin, MD, and the PROTEUS Trial
GLP-1s and Inflammation: The Missing Story! NEW RESEARCH
Seniors No 1 Oncologist Reveals Foods to Starve Cancer Cells Naturally After 50! |Dr. William Li
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis
I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.
Melania Trump's NEW FACE | Plastic Surgery Analysis
007 FIRST LIGHT Ending Felt Like A Movie
The GLP-1 War Escalates: Lilly vs. Novo
Colin Farrell Opens Up About His Son With Angelman Syndrome | PEOPLE
The End of the Petrodollar? How Iran War Is Reshaping the Global Economy: Author Laleh Khalili
Why Speech Therapy after Brain Injury Part 01 | Tracy Leckenby, Speech Pathologist
It's NOT Memory - 5 Early Dementia Signs Everyone Misses
Why GLP-1s may or may not be for you | Chasing Life
The French Do Not Care About Work
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
Golden Retriever Meets Completely Broken Rescue for the First Time
I’m a Pathologist. Retatrutide is NOT Ozempic. It’s Biological Overdrive.
I Used 100% CASTOR OIL Eye Drops for 30 days - Here's What happened
Short statured people answer questions you're too afraid to ask | You Can't Ask That | Full Episode
